Anti-angiogenic therapy: current challenges and future perspectives

F Lopes-Coelho, F Martins, SA Pereira… - International journal of …, 2021 - mdpi.com
Anti-angiogenic therapy is an old method to fight cancer that aims to abolish the nutrient and
oxygen supply to the tumor cells through the decrease of the vascular network and the …

A look at the importance of chirality in drug activity: Some significative examples

J Ceramella, D Iacopetta, A Franchini, M De Luca… - Applied Sciences, 2022 - mdpi.com
Chirality plays an important role in the development of many pharmaceuticals, being a
general property of 'handedness'; nevertheless, a large number of pharmaceuticals are still …

New drugs are not enough-drug repositioning in oncology: An update

RG Armando, DLM Gomez… - … Journal of Oncology, 2020 - spandidos-publications.com
Drug repositioning refers to the concept of discovering novel clinical benefits of drugs that
are already known for use treating other diseases. The advantages of this are that several …

Emerging applications of anti-angiogenic nanomaterials in oncotherapy

B Tang, W Ma, Y Lin - Journal of Controlled Release, 2023 - Elsevier
Angiogenesis is the process of generating new blood vessels from pre-existing vasculature.
Under normal conditions, this process is delicately controlled by pro-angiogenic and anti …

Novel immunomodulatory drugs and neo-substrates

S Gao, S Wang, Y Song - Biomarker Research, 2020 - Springer
Thalidomide, lenalidomide and pomalidomide are immunomodulatory drugs (IMiDs)
effective in the treatment of multiple myeloma, myelodysplastic syndrome (MDS) with …

A comprehensive review on the efficacy of several pharmacologic agents for the treatment of COVID-19

F Haddad, G Dokmak, R Karaman - Life, 2022 - mdpi.com
Simple Summary Treatments for coronavirus disease-2019 (COVID-19) have utilized a
variety of medications, including antivirals, immunomodulators, and other therapeutics such …

Drug design targeting active posttranslational modification protein isoforms

F Meng, Z Liang, K Zhao, C Luo - Medicinal research reviews, 2021 - Wiley Online Library
Modern drug design aims to discover novel lead compounds with attractable chemical
profiles to enable further exploration of the intersection of chemical space and biological …

Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agents

AR Kotb, AE Abdallah, H Elkady, IH Eissa… - RSC …, 2023 - pubs.rsc.org
Immunomodulatory medications like thalidomide and its analogs prevent the production of
some proinflammatory cytokines linked to cancer. A new series of thalidomide analogs were …

Chirality of new drug approvals (2013–2022): trends and perspectives

RU McVicker, NM O'Boyle - Journal of Medicinal Chemistry, 2024 - ACS Publications
Many drugs are chiral with their chirality determining their biological interactions, safety, and
efficacy. Since the 1980s, there has been a regulatory preference to bring single enantiomer …

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

L Zhang, A Zhao, M Duan, Z Li, X Cao… - Blood, The Journal …, 2019 - ashpublications.org
Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder. The
anti–interleukin 6 (IL-6) therapy siltuximab is not available everywhere, and is not effective …